Literature DB >> 8238795

Allergens of Pityrosporum ovale and Candida albicans. II. Physicochemical characterization.

G Doekes1, M J Kaal, A G van Ieperen-van Dijk.   

Abstract

Pityrosporum ovale has recently been recognized as a source of allergens to which many patients with atopic dermatitis (AD) show type I skin reactions and specific IgE antibodies. In this study the IgE-binding components and/or epitopes in P. ovale extract were shown to be partially sensitive to pronase or trypsin treatment, whereas periodate oxidation resulted in a complete loss of IgE-binding capacity, thus suggesting the involvement of carbohydrate structures. In Con A affinity chromatography most of the IgE-binding capacity of crude P. ovale extract bound to the column, and could be eluted with mannoside. Gel filtration on Sephacryl S-400 revealed a marked heterogeneity with respect to molecular mass, with most of the IgE-binding activity associated with high-mol.-mass fractions (from 5 x 10(4) up to 2 x 10(6) Da). A similar heterogeneity was found after chromatofocusing, with IgE-binding in the whole pI-range from 7.0 to 4.0. Essentially identical results were obtained with extracts of Candida albicans, in agreement with the previously shown cross-reactivity of IgE-binding components in the two yeast extracts. In inhibition ELISA, gel filtration and chromatofocusing fractions containing components with widely different mol. mass or pI showed complete reciprocal cross-inhibition, and were all capable of inhibiting the binding of IgE to unfractionated extracts. We therefore conclude that the cross-reacting anti-P. ovale/anti-C. albicans IgE antibodies in the sera of AD patients are mainly directed at a restricted number of carbohydrate epitopes that are expressed on a heterodisperse range of high-mol.-mass components, probably mannans or mannoproteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238795     DOI: 10.1111/j.1398-9995.1993.tb00737.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

Review 1.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 2.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  Atopic dermatitis and fungi.

Authors:  Jan Faergemann
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 4.  Fungal allergens.

Authors:  W E Horner; A Helbling; J E Salvaggio; S B Lehrer
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

5.  Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE.

Authors:  O Bäck; A Scheynius; S G Johansson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  IgG and IgE immune response against the surface glycoprotein gp200 of Saccharomyces cerevisiae in patients with atopic dermatitis.

Authors:  P Nenoff; B Müller; U Sander; G Kunze; M Bröker; U F Haustein
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.